MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2147/jmdh.s330958

Медицинская библиотека · Journal of multidisciplinary healthcare · 2021

ABO Blood Group and Outcomes in Patients with COVID-19 Admitted in the Intensive Care Unit (ICU): A Retrospective Study in a Tertiary-Level Hospital in Bangladesh.

Halim Mohammad Rabiul, Saha Shuvajit, Haque Injamam Ull, Jesmin Sadia, Nishat Rahatul Jannat, Islam A S M D Ashraful, Roy Seema, Haque Miah Md Akiful, Islam Md Motiul, Hamid Tarikul, Ahmed Kazi Nuruddin, Talukder Md Azharul Islam, Ahmed Arif, Hasan Emran, Ananna Nurjahan, Mohsin Faroque Md, Hawlader Mohammad Delwer Hossain

СтатьяПеревод в очереди

Аннотация

PURPOSE: The world is heavily suffering from the COVID-19 pandemic for more than a year, with over 191 million confirmed cases and more than 4.1 million deaths to date. Previous studies have explored several risk factors for coronavirus disease 2019 (COVID-19), but there is still a lack of association with ABO blood type. This study aimed to find out the relationship between the ABO blood group and COVID-19 outcomes in Bangladesh.

SUBJECTS AND

METHODS

This retrospective cross-sectional study was conducted in the intensive care unit (ICU) of a tertiary-level COVID-dedicated hospital in Dhaka city, Bangladesh, between April 2020 and November 2020. Records from 771 critically ill patients were extracted who were confirmed for COVID-19 by reverse transcriptase-polymerase chain reaction (RT-PCR) assay, and blood grouping records were available in the health records.

RESULTS

The blood groups were 37.35%, 17.38%, 26.46%, and 18.81% for A, B, AB, and O type, respectively. Clinical symptoms were significantly more common in patients with blood type A (p < 0.05). Patients with blood type A had higher WBC counts and peak serum ferritin levels and both were statistically significant (p < 0.001). Patients with blood type A had a greater need for supplemental oxygen, and they were more likely to die in comparison to the patients with other blood types (p < 0.05). In multivariable analysis, our primary outcome death was significantly associated with blood type A (AOR: 3.49, 95% CI: 1.57-7.73) while adjusting for age, male gender, and non-communicable diseases.

CONCLUSION

Based on this study results, it can be concluded that the COVID-19 patients with blood type A have a higher chance of death and other complications. The authors recommend blood grouping before treating the COVID-19 patients, and healthcare workers should prioritize treating the patients based on that result.

Для цитирования: Halim Mohammad Rabiul, Saha Shuvajit, Haque Injamam Ull, Jesmin Sadia, Nishat Rahatul Jannat, Islam A S M D Ashraful, Roy Seema, Haque Miah Md Akiful, Islam Md Motiul, Hamid Tarikul, Ahmed Kazi Nuruddin, Talukder Md Azharul Islam, Ahmed Arif, Hasan Emran, Ananna Nurjahan, Mohsin Faroque Md, Hawlader Mohammad Delwer Hossain. ABO Blood Group and Outcomes in Patients with COVID-19 Admitted in the Intensive Care Unit (ICU): A Retrospective Study in a Tertiary-Level Hospital in Bangladesh.. Journal of multidisciplinary healthcare. 2021. DOI: 10.2147/jmdh.s330958.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.